Search Results 1621-1630 of 2810 for 씨밀레토토

  1. A Study to Examine Diabetes Control and Patient Reported Outcomes Among Kidney Transplant Recipients with Type 2 Diabetes - Mayo Clinic

    It also aimes to evaluate immunosuppression related patient reported outcomes in kidney transplant recipients with type 2 diabetes. Participation eligibility.

  2. A Study Of Subcutaneous Daratumumab Versus Active Monitoring In Participants With High-Risk Smoldering Multiple Myeloma - Mayo Clinic

    The primary objective of this study is to determine whether treatment with daratumumab administered subcutaneously (SC) prolongs progression-free survival (PFS) ...

  3. A Study of Cells in the Blood that may be Contributing to Allergic Inflammation in Asthmatics - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. A Study of the Prevalence and Characteristics of Multiple Sclerosis Related Hypothermia - Mayo Clinic

    About this study · To assess the prevalence of episodic hypothermia among multiple sclerosis (MS) patients evaluated at Mayo Clinic. · To characterize clinical, ...

  5. A Study To Evaluate A Multi-target Stool DNA Test, Cologuard, For Colorectal Cancer (CRC) Screening In Individuals Aged 45-49 And At Average Risk For Development Of Colorectal Cancer - Mayo Clinic

    A Study To Evaluate A Multi-target Stool DNA Test, Cologuard, For Colorectal Cancer (CRC) Screening In Individuals Aged 45-49 And At Average Risk For ...

  6. A Study To Evaluate INO-3107 With Electroporation (EP) In Participants With HPV-6- And/or HPV-11-Associated Recurrent Respiratory Papillomatosis (RRP) - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness, safety, tolerability and immunogenicity (ability to produce immune response) of INO-3107 in ...

  7. A Phase I, Multi-Center, Open Label, Dose De-escalation And Expansion Study Of Gemcitabine And Cisplatin With AG120 Or Pemigatinib For Advanced Cholangiocarcinoma - Mayo Clinic

    Ivosidenib and pemigatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving gemcitabine and cisplatin with ...

  8. Long-term Safety And Tolerability Of Atacicept (Long-term Follow-Up Of Patients Who Participated In ADDRESS II) - Mayo Clinic

    About this study. This is a multicenter, double-blind, Phase 2b, long-term extension (LTE) to the ADDRESS II core trial (EMR 700461-023) (NCT01972568), ...

  9. Study Of Encorafenib + Cetuximab Plus Or Minus Binimetinib Vs. Irinotecan/Cetuximab Or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With A Safety Lead-in Of Encorafenib + Binimetinib + Cetuximab In Patients With BRAF V600E-mutant Metastatic Colorectal Cancer - Mayo Clinic

    Study Of Encorafenib + Cetuximab Plus Or Minus Binimetinib Vs. Irinotecan/Cetuximab Or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/ ...

  10. Calcineurin Inhibitor-Free Interventions For Prevention Of Graft-versus-Host Disease (BMT CTN 1301) - Mayo Clinic

    About this study. The study is designed as a three arm randomized Phase III, multicenter trial comparing two calcineurin inhibitor (CNI)-free strategies for ...